We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Gynaecology
Digital Poster
Brachytherapy
Surgery or Chemoradiotherapy for Node-Negative Cervical Cancer FIGO 2018 IB2 30–39 mm: Does Chemoradiotherapy Reduce the Risk of Distant Relapse?
ABEL CORDOBA , France
-323
UNICURE?HD: Single?Insertion Image?Guided HDR Brachytherapy for Locally Advanced Cervical Cancer — Multicenter French Cohort
Lucie Houdou, France
-413
Mapping multi-regional regional brachytherapy practice for cervical cancer: results of a comprehensive survey
Khadiga Mohammed, New Zealand
-536
Short course adjuvant vaginal cuff brachytherapy (VCB) in early endometrial cancer compared to standard of care (SAVE)
Lindsay Burt, USA
-851
Prospective dosimetric–clinical correlation of CT-based contouring incorporating pre-brachytherapy MRI in cervical cancer brachytherapy
Harismita Devi, India
-945
Needle Navigation in Interstitial Brachytherapy: Combining Infrared Tracking and Radiography for Real-Time Implantation Guidance
Andre Karius, Germany
-952
Fast automated catheter configuration planning in intracavitary/interstitial cervical cancer brachytherapy
Robin Straathof, The Netherlands
-1228
External Beam Radiotherapy Boost with Intracavitary Brachytherapy Versus Interstitial Brachytherapy in Cervical Cancer: A Multi-Institution Experience
Vannesza Hendricke Chua, Philippines
-1511
Are current MRI-guided brachytherapy techniques sufficient for large cervical tumors? A dose–volume analysis in a large cohort
GREGOIRE LAURENT DELANGHE, France
-1596
High-Dose-Rate Versus Pulse-Dose-Rate Brachytherapy in Vulvovaginal Cancers: Comparison of Acute Toxicities
Alizée RENAN, France
-1915
3D printed applicators for gynecologic tumors: feasibility and dosimetric benefits
Barbara Helena Zobec Logar, Slovenia
-1938
Multimodality image-guided hybrid brachytherapy for LACC: real-world dosimetry, outcomes and dose–response in 120 patients
Yuanjie Cao, China
-2003
Treatment approach and outcome in patients with locoregional recurrent endometrial cancer.
Heidi Rutten, The Netherlands
-2134
Clinical audit of combined intracavitary interstitial brachytherapy using Utrecht applicator in locally advanced cervical cancer
Aparna Mullangath Prakasan, India
-2251
Radio-chemotherapy and interventional radiotherapy (modern brachitherapy) in vaginal carcinoma: a monocentric experience
Valentina Lancellotta, Italy
-2291
Image-guided interventional radiotherapy (modern brachytherapy) boost for vaginal cuff recurrences
Valentina Lancellotta, Italy
-2302
IMAGE-GUIDED INTERVENTIONAL RADIOTHERAPY (MODERN BRACHYTHERAPY) FOR THE TREATMENT OF HIGH-GRADE VAGINAL INTRAEPITHELIAL CANCER
Valentina Lancellotta, Italy
-2310
Predicting HRCTV D90 Using Pre-HRCTV Shape Features and Interstitial Catheter Number
Amani Chowdhury, United Kingdom
-2456
Impact of Iridium Source Decay on outcomes of Image-Guided Brachytherapy for locally advanced cervical cancer
Arunima Nagar, India
-2566
Optimizing and Evolving HDR Brachytherapy in Resource-Limited Settings for Locally Advanced Cervical Cancer
Suriana Sultana, Bangladesh
-2610
Urethral toxicity related to dose-volume parameters in brachytherapy for gynecological cancer.
Evita Mentink, The Netherlands
-2806
Dosimetric and Clinical Efficacy Evaluation of Freehand and 3D-PT-Assisted HDR-ISBT for Central Pelvic Recurrent Gynecologic Malignancies Post-RT
Junjie Wang, China
-3080
Clinical Results of Image-Guided Adaptive Brachytherapy After Chemoradiotherapy for Cervical Cancer: Experience from Hospital Carlos Van Buren, Chile
Darlett Folch Mora, Chile
-3613
Initial Outcome of advanced vaginal recurrences treated with EBRT and MR Adaptive Interstitial Brachytherapy using GEC-ESTRO(ACROP)–ABS–CBG guidelines
HARJOT KAUR BAJWA, India
-3624
MR-IGABT for locally advanced cervical cancer in Hong Kong: long term institutional outcomes from a decade of evolution in radiotherapy standards
Philip Yuguang Wu, China, Hong Kong Special Administrative Region
-3664
Comparative cost-benefit of electronic versus HDR iridium-192 brachytherapy for exclusive vaginal cuff treatment in postoperative endometrial cancer
Víctor González, Spain
-3820
Dosimetric Outcomes of Mucosa-Sparing Brachytherapy Using a Vaginal Cylinder and Planned with the HIPO Algorithm in Endometrial Cancer
SUMERYA DURU BIRGI, Turkey
-3932
Comparison of Reference Point, Reference Line, and Inverse Optimization in 3-D Vaginal Cuff Brachytherapy Using an Ovoid Applicator
Mehmet Varol, Turkey
-4345
Feasibility and Efficacy of MRI-Guided Adaptive Brachytherapy for locally Advanced Cervical Cancer: A Prospective Cohort Study
Fatma A. Rikabe, Egypt
-4643
Dosimetric evaluation for CTV delineation in adjuvant vaginal cuff brachytherapy: impact of applicator inclusion
Lisa Vicenzi, Italy
-4871
DEFINITIVE IMAGE-GUIDED RADIOTHERAPY VS SURGERY IN MEDICALLY INOPERABLE EARLY-STAGE ENDOMETRIAL CANCER: A MATCHED COMPARATIVE STUDY
Dina Najjari Jamal, Spain
-4878
Modeling urethral dose–toxicity relationship in image-guided brachytherapy for gynecological cancers: dosimetric assessment of genitourinary morbidity
Ana Paula Galerani Lopes, Oman
-4965
Peri-operative complications in gynaecological brachytherapy – a tertiary centre experience
Mohammed Abdul-Latif, United Kingdom
-4992
Image-guided adaptive brachytherapy in locally advanced cervical cancer: lessons from a developing country on dosimetric predictors and outcome
Elena Manea, Romania
-5004
Trends in brachytherapy use and survival in cervical cancer: Insights from a high-volume oncology centre in Nigeria.
Adedayo Joseph, Nigeria
-5072